The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain  by Balda, Maria S. et al.
FEBS Letters 399 (1996) 326-332 FEBS 17958 
The SH3 domain of the tight junction protein ZO-1 binds to a serine 
protein kinase that phosphorylates a region C-terminal to this domain 
Maria S. Balda a,*, James M. Anderson b, Karl Matter a 
~Department of Cell Biology, Science III, University of Geneva, 30, Quai Ernest-Ansermet, 1211 Geneva 4, Switzerland 
bDepartment of Internal Medicine and Cell Biology, Yale School of Medicine, New Haven, CT, USA 
Received 10 September 1996; revised version received 7 November 1996 
Abstract ZO-1 is a tight junction phosphoprotein partially 
homologous to a tumor suppressor in Drosophila. The homo- 
logous region contains an SH3 domain with an unidentified 
function. Using fusion proteins containing the SH3 domain and 
various N- and C-terminal sequences, we tested for association of 
a kinase with this protein domain in extracts of MDCK cells. We 
show that the SH3 domain of ZO-I binds a serine protein kinase 
that phosphorylates a region immediately C-terminal to the SH3 
domain. This kinase associates pecifically with the SH3 domain 
of ZO-I and appears to be also associated with junctional 
complexes extracted from MDCK cells. 
Key words: Tight junction; ZO-1; SH3 domain; Serine 
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1. Introduction 
To understand the development of multicellular tissues and 
the pathology of cancer, it is necessary to know more about 
the regulation of cell-cell adhesion and the assembly and dis- 
assembly of intercellular junctions. The epithelial junctional 
complex is formed by gap junctions, desmosomes, adherens 
junctions and tight junctions [1]. Some proteins that localize 
to these structures have been identified as oncogenes or tumor 
suppressors suggesting that intercellular junctions form a spe- 
cialized signal transduction complex that regulates cell growth 
and differentiation [2-4]. For this reason, the identification 
and characterization f new junctional components with en- 
zymatic properties enabling them to either transmit signals or 
regulate the interplay of structural components of intercellular 
junctions is of primary cell biological importance and is likely 
to improve our understanding of the regulation of cell growth 
and differentiation. 
Tight junctions are the most apical structure of the junc- 
tional complex between epithelial cells. They regulate the dif- 
fusion of molecules through the paracellular pathway and 
participate in the maintenance of the differential distribution 
of lipids and, perhaps, some proteins between the apical and 
the basolateral cell surface domain [5]. Several peripheral 
membrane proteins that localize at the tight junction have 
been identified but only two have been sequenced: ZO-1 [6- 
8] and ZO-2 [9,10]. Both proteins how homology to a tumor 
suppressor in Drosophila, disc large A (dlgA). This growing 
family of proteins includes also lin-2, a component of the ras 
pathway that induces vulval differentiation in C. elegans, 
SAP90/PSD95, a protein associated with synapses, and p55, 
a cytoskeletal protein of the erythrocyte membrane [11-15]. 
These proteins possess a domain homologous to yeast guany- 
late kinase, an SH3 domain, and, three repeated regions called 
PDZ (for PSD95, Dig A and ZO-1) domain. Interestingly, 
PDZ repeats eem to be important for the clustering of signal 
transduction molecules at specific membrane domains (re- 
viewed in [16]). In contrast, nothing is known about molecules 
interacting with the SH3 domain of any member of this pro- 
tein family. 
SH3 domains were originally found in non-receptor protein 
tyrosine kinases of the Src family [17-19]. Since then, how- 
ever, SH3 domains have been found in various proteins in- 
volved in different enzymatic as well as structural functions. 
Furthermore, since SH3 domains interact with specific PXXP 
motifs of other proteins, this protein domain appears to be a 
rather general mediator of protein-protein i teractions [20- 
24]. Interestingly, the SH3 domains of Src, Nck, and Grb2 
have been shown to interact with kinases, suggesting that this 
type of protein domain can also provide a link to other reg- 
ulatory components [25-27]. 
Protein kinases appear to play a central role in the regula- 
tion of tight junction sealing [28-37]. Pharmacological studies 
suggested that the assembly of tight junctions in a Ca-switch 
model is directly or indirectly regulated by protein kinase C as 
well as other signal transducers like G-proteins, phospholipase 
C, and calmodulin [38,39]. Conversely, the disassembly of the 
junctional complex is also regulated by protein kinases [40]. 
In an effort to identify proteins interacting with the tight 
junction protein ZO-1 we used fusion proteins to identify 
associated proteins. Because almost all proteins associated 
with tight junctions are phophoproteins, we investigated 
whether fusion proteins containing parts of ZO-1 associate 
with a kinase that also phosphorylates the fusion protein. 
We show here that the SH3 domain of ZO-1 binds a serine 
kinase that phosphorylates a region C-terminal to this do- 
main. This kinase can utilize GTP as a phosphoryl donor 
instead of ATP, and does not associate with other SH3 do- 
mains like those of Abl, Src, Crk, Grb2 or Nck. Moreover, 
immunoprecipitates of ZO-1 extracted from MDCK cells were 
also found to contain a kinase activity that phosphorylated 
the same fusion protein. 
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2. Materials and methods 
2.1. Construction ffusion proteins 
Fusion proteins consisting of glutathione S-transferase (GST) 
spliced to different parts of ZO-1 were generated using the pGEX- 
3X vector (Pharmacia, Uppsala, Sweden). For the extended PDZ3- 
SH3 fusion protein, a fragment obtained by digestion of the human 
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ZO-1 cDNA [7] with StuI was ligated into the SrnaI site of pGEX-3X. 
All other fusion proteins containing the SH3 domain and various 
neighboring regions were generated by PCR using a 5'-primer con- 
taining a BamHI site and a 3'-primer containing an in-frame stop 
codon followed by an EcoRI site. PCR products were generated 
with Pfu polymerase (Strategene, USA) and cloned into the BamHI 
and EcoRI sites of pGEX-3X (see Fig. 2). Fusion proteins encoding 
th~ SH3 domains of Abl, Src, nSrc, Crk and full-length Grb2 and Nck 
were kindly provided by Bruce Mayer (Department of Microbiology 
apd Molecular Genetics, Harvard Medical School) [41,42]. GST fu- 
si, n proteins were prepared and purified as described [43]. 
2. '. Cell culture and preparation of cell lysates 
MDCK cells were cultured in DMEM supplemented with 10% of 
fe:al calf serum and antibiotic as described [44]. Cells from confluent 
di-.hes were washed twice in ice-cold phosphate-buffered saline con- 
taming 1 mM PMSF, scraped off, and pelleted. The cell pellets were 
ly-ed in PBS containing 1% Triton X-100 and 1 mM phenylmethyl- 
st~tphonyl fluoride. Lysates were spun for 10 min at 13000 rpm in a 
m crocentrifuge and the supernatants were either directly used or 
st )red at -80°C. 
2. T. Kinase assays, phosphoamino acid analysis, and 
immunoprecipitation 
For GST-fusion protein pull-down assays, approx. 1 3 Ixg of fusion 
p~otein and 40 pl of glutathione-Sepharose beads (1:2 slurry) were 
u~ed per precipitation with 500 I.tl of MDCK cell extract containing 
If ~0-200/ag of total soluble proteins. Incubation of the fusion protein 
th the cell extract was carried out overnight at 4°C on an end-over- 
eld rotator. Then, samples were spun and washed three times with 
PBS containing 1% Triton X-100 and twice with 50 mM HEPES, pH 
7-~. Kinase reactions were carried out in 40 I.tl of kinase buffer (50 
n~M HEPES pH 7.4, 10 mM MgCI2, 2 mM MnC12) containing 2.5 
laCi of [y-32p]ATP (Hartman Analytic, Germany, l 1 Ci/mmol). Reac- 
ti,ms were performed at 30°C for 60 min and terminated by adding 
SDS-PAGE sample buffer followed by heating for 10 min at 75°C. 
Samples were fractionated on 8-20% gradient mini SDS-PAGE gels 
aad phosphorylated bands were visualized by autoradiography. 
Phosphoamino acid analysis was conducted as previously described 
udng 2-dimensional thin-layer electrophoresis [45]. Immunoprecipita- 
ti )ns where performed as described [39] using the monoclonal anti- 
b,)dy R40.76 specific for ZO-1 [46] coupled to CNBr-activated Se- 
paarose. Control incubations were performed with inactivated 
S.~'pharose. The same buffer as used for the pull-down assay described 
above was employed and the in vitro kinase assay was performed in 
the presence of 1 mM Na3VO4 and 50 ng/txl of okadeic acid. 
3. Results 
3.1. The SH3 domain o f  ZO-1 binds a serine kinase 
The homologous region between the tight junction protein 
ZO-1 and the Drosophila tumor suppressor protein dlgA con- 
tains an SH3 domain [7]. SH3 domains are often found in 
signal transduction proteins and generally bind to proline- 
rich sequences of specific proteins [17,24,19]. To identify the 
signal transduction pathway that regulates tight junction as- 
sembly and sealing, we sought to identify the protein(s) which 
interact(s) with the SH3 domain of ZO-1. To do this, we 
generated a fusion protein consisting of GST and amino acids 
295-633 of ZO-1, which include the third PDZ domain as well 
as the SH3 domain. Because tight junction assembly and seal- 
ing has been shown to be regulated by kinases, we investi- 
gated first whether this fusion protein binds to a kinase that 
also phosphorylates it.
Fig. 1A shows that when the fusion protein containing the 
third PDZ domain and the SH3 domain of ZO-1 (GST- 
PDZ3-SH3ex) was incubated with MDCK cell extract, exten- 
sively washed and then tested in vitro for kinase activity, very 
strong phosphorylation of the fusion protein was observed 
(Fig. 1A, lane 1). The specificity of this interaction was as- 
sessed by incubating GST with cell extract and, after extensive 
washing, 2 ~tg of the GST-PDZ3-SH3ex fusion protein was 
added prior to the in vitro kinase assay. No phosphorylation 
of the fusion protein was observed in such samples (Fig. 1A, 
lane 2). This experiment shows that the fusion protein con- 
taining the third PDZ repeat and the SH3 domain of ZO-1 
binds to a protein kinase that phosphorylates the fusion pro- 
tein itself. 
Kinases can be classified by the amino acid that they phos- 
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I'ig. 1. The SH3 domain of ZO-1 binds to a serine kinase. (A) A fusion protein containing the third PDZ and the SH3 domain of ZO-1 (GST- 
PDZ-SH3ex) or GST only was incubated with MDCK cell extract, extensively washed and associated proteins were tested for kinase activity in 
~itro. 2 I.tg of GST-PDZ3-SH3ex was added to the GST bound proteins. (B) The band of the phosphorylated ZO-1 fusion protein was excised 
l rom the gel and subjected to phosphoamino acid analysis. Indicated are the positions of phosphoserine, phosphothreonine and phosphotyro- 
sine. (C) Two different GST fusion proteins containing only the SH3 domain (apparent molecular mass of approx. 35 kDa) were generated and 
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Fig. 2. The kinase phosphorylates serine residue(s) C-terminal to the SH3 domain. Several constructs containing the SH3 domain and different 
C- and N-terminal sequences were generated according to the schematic description in the bottom part of the figure and labeled from A to G. 
These fusion proteins were analyzed for phosphorylation in vitro. Autoradiographs are indicated as 32p and Coomassie stains as C. The letter 
underneath each set of gels corresponds to the letter indicated in the schematic representation f the constructs. 
no acid analysis of the GST-PDZ3-SH3ex fusion protein 
phosphorylated in vitro. Fig. 1B shows that the only phos- 
phorylated amino acid we could detect was phosphoserine. 
Phosphorylation on tyrosine residues could also not be de- 
tected when the in vitro phosphorylated fusion protein was 
probed with anti-phosphotyrosine a tibodies on immunoblots 
(not shown). Therefore, the precipitated kinase appears to 
phosphorylate he fusion protein only on serine residues. In- 
terestingly, ZO-1 also contains phosphoserine (as well as 
phosphothreonine) in vivo [46], suggesting that ZO-1 could 
indeed be a physiological substrate for the precipitated kinase. 
To determine whether the kinase binding site is indeed the 
SH3 domain of ZO-1, we generated two different GST fusion 
proteins containing the SH3 domain (SH3(I), amino acids 
496-579; SH3(2), amino acids 506-579, apparent molecular 
masses approx. 35 kDa). These fusion proteins were subjected 
to the same assay as that described in Fig. 1A, however, no 
phosphorylation f the fusion proteins could be detected (Fig. 
1C, lanes 1,2). This negative result could have been due either 
to failure of the kinase to bind to these shorter fusion proteins 
or, alternatively, to the fact that they do not contain the 
phosphorylation site(s). Therefore, we added the original fu- 
sion protein as a substrate to the kinase assays performed 
with the precipitates of the SH3-fusion proteins. Indeed, this 
experiment demonstrated that the SH3-fusion proteins precip- 
itated the kinase since phosphorylation of the GST-PDZ3- 
SH3ex fusion protein could be detected (Fig. 1C, lanes 3,4). 
Thus, the SH3 domain of ZO-1 appears to be sufficient o 
bind the kinase but does not contain the phosphorylation 
site(s). 
To localize the phosphorylation site(s), we generated iffer- 
ent fusion proteins containing the SH3 domain, to ensure 
binding of the kinase, and different upstream and downstream 
sequences as shown in Fig. 2. Fusion proteins lacking either 
only the additional sequences N-terminal to the third PDZ 
domain (Fig. 2B) or also the PDZ domain and some addi- 
tional amino acids linking the latter domain to the SH3 do- 
main (Fig. 2C) were phosphorylated to a degree similar to 
that of the original fusion protein (Fig. 2A: GST-PDZ3- 
SH3ex). Furthermore, an additional short C-terminal deletion 
also did not affect the observed phosphorylation (Fig. 2D). As 
described in Fig. IC, a fusion protein containing only the SH3 
domain did not become phosphorylated (Fig. 2E). However, 
the Coomassie staining shows that this fusion protein was not 
very stable and became degraded. Even though the experiment 
in Fig. 1C showed that this small amount of fusion protein 
was still capable of binding the kinase, the absence of phos- 
phorylation could have been due to the low amount of pro- 
tein. Therefore, we assessed whether fusion proteins analo- 
gous to D and E but containing in addition the third PDZ 
domain would exhibit a similar phosphorylation behavior. 
Indeed, the fusion protein containing no amino acids C-ter- 
minal to the SH3 domain did not become phosphorylated 
(Fig. 2F) while the one which included amino acids 579-604 
was phosphorylated (Fig. 2G). This result shows that the ma- 
jor, if not the only, phosphorylation site is within residues 
579-604. Interestingly, the phosphorylated region contains 
only two serine residues that are immediately adjacent o 
each other ($597S598), These two serine residues are within a 
basic environment that is similar to the consensus ite for 
protein kinase C [47]. Interestingly, H7 and staurosporine, 
inhibitors of protein kinase C as well as other protein kinases, 
inhibit tight junction assembly and disassembly upon addition 
or removal, respectively, of calcium [38-40,48,49]. Further- 
more, protein kinase C purified from brain phosphorylates 
immunoprecipitated ZO-1 in vitro, and protein kinase C 
localizes at the lateral membrane of MDCK cells [50]. There- 
fore, we determined next whether the kinase activity was in- 
hibited by staurosporine. Since we did not observe inhibition 
by staurosporine at low concentrations (10 nM or less), it is 
not likely that the precipitated kinase is protein kinase C (not 
shown). In contrast, 100 nM staurosporine inhibited phos- 
phorylation of the GST-PDZ3-SH3ex fusion protein by ap- 
prox. 50% (not shown). Since such high concentrations of 
staurosporine inhibit many kinases including protein kinase 
C, protein kinase A, tyrosine kinases and myosin light chain 
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tig. 3. The serine kinase binds specifically to the SH3 domain of ZO-I. Fusion proteins containing SH3 domains of Abl, Crk, Src, nSrc, or the 
eatire coding sequences of Grb2 and Nck were bound to glutathione beads, incubated with MDCK cell extract, and then assayed for kinase ac- 
tivity by adding GST-PDZ3-SH3ex fusion protein as substrate (lanes 1 6). Alternatively, the kinase precipitated with the GST-PDZ3-SH3ex fu- 
s on protein was tested by adding the above-described fusion proteins as additional substrates (lanes 7-13). 
Linase [51], we analyzed whether antibodies pecific for those 
~,inases (anti-protein kinase C ~ from Boehringer Mannheim; 
~nti-protein kinase A R-I and R-II kindly provided by B.A. 
l lemmings, Friedrich Miescher Institute, Basel, Switzerland 
J52]; and anti-myosin light chain kinase from Sigma) would 
~lso precipitate the kinase that phosphorylates the GST- 
I'DZ3-SH3ex fusion protein. However, we did not observe 
l~hosphorylation f the fusion protein in kinase assays with 
~hese immunoprecipitates. The kinase assay of the immuno- 
l,recipitated kinases showed phosphorylated proteins of mo- 
lecular weight different from that of the fusion protein which 
an be taken as a control that the immunoprecipitated kinases 
vere indeed active but did not phosphorylate he fusion pro- 
~ein. Furthermore, chelerythrine, a kinase inhibitor more spe- 
,:ific for protein kinase C than staurosporine, [53] did not 
nhibit kinase activity (data not shown). 
Next, we characterized some of the biochemical properties 
)f  the ZO-I SH3-binding kinase. The original assay condi- 
'ions tested included 10 mM magnesium and 2 mM manga- 
lese, therefore, we analyzed whether both cations are required 
or  optimal activity. We obtained the same activity using 12 
,nM of either magnesium or manganese. Replacement by cal- 
,-ium, cadmium or zinc did not give full activity (data not 
;how). Furthermore, the precipitated kinase was capable of 
asing GTP instead of ATP as phosphoryl donor (not shown). 
known kinase that is capable of using GTP instead of ATP 
s casein kinase II [54]. However, we could not detect this 
dnase in fusion protein precipitates using specific antibodies 
Boehringer Mannheim, not shown) for immunoblot and the 
mmunoprecipitated casein kinase II did not significantly 
3hosphorylate he fusion protein (data not shown). Further- 
aaore, the phosphorylated serine residue(s) are not within a 
~'onsensus site for casein kinase II phosphorylation. 
~.2. The kinase associated with the SH3 domain of ZO-1 does 
not associate with the SH3 domains of Abl, Src, Crk, Grb2 
or Nck 
To characterize the specificity of the kinase associated with 
the SH3 domain of ZO-1 we analyzed other SH3 domains 
such as those of Abl, Src, nSrc, Crk, and full length Grb2 
and Nck (GST fusion proteins were kindly provided by Bruce 
Mayer). First, we incubated the different fusion proteins with 
MDCK cell extracts and, after washing, the PDZ3-SH3ex 
fusion protein was added and an in vitro kinase assay was 
performed and SDS-PAGE analysis was carried out. 
Fig. 3 shows that none of these fusion proteins precipitated 
a kinase that was capable of phosphorylating the GST-PDZ3- 
SH3ex fusion protein. Thus, the SH3 domain of ZO-1 binds 
to a kinase that does not associate with the SH3 domains of 
Abl, Src, nSrc, Crk, and full-length Grb2 and Nck. This not 
only suggests that binding to the SH3 domain of ZO-1 is 
specific but also rules out that the kinase that binds to the 
SH3 domain of ZO-1 is identical to one of the protein kinases 
that bind to the SH3 domain of Src and Nck [25,26]. 
To examine also the specificity of the phosphorylation, we 
added the above-mentioned purified fusion proteins as sub- 
strates to kinase assays of precipitates generated with the 
GST-PDZ3oSH3ex fusion protein. This experiment showed 
that only the GST-PDZ3-SH3ex fusion protein became phos- 
phorylated (Fig. 3). This suggests not only that binding to the 
SH3 domain of ZO-I is specific but also that not just any SH3 
domain-containing protein can serve as a substrate for this 
kinase. 
3.3. A kinase that phosphorylates the GST-PDZ3-SH3ex 
.fusion protein co-immunoprecipitates with ZO-I 
In vivo ZO-1 is phosphorylated on Ser and Thr [46]. To 
evaluate whether ZO-1 is associated to a kinase in vivo that 
may phosphorylate he PDZ3SH3 fusion protein, we immu- 
noprecipitated ZO-1 with a specific monoclonal antibody 
(R40.76) [46] and then analyzed the immunoprecipitate in 
an in vitro kinase assay in the absence or presence of the 
GST-PDZ3-SH3ex fusion protein. 
Fig. 4 shows that the GST-PDZ3-SH3ex fusion protein 
only became phosphorylated when it was added to a kinase 
assay with precipitates generated with beads carrying the anti- 
ZO-I antibody (lane 2) but not if it was added to a assay with 
negative beads (lane 1). Furthermore, a phosphorylated band 
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Fig. 4. ZO-1 co-precipitates with a kinase that phosphorylates the 
PDZ3-SH3 ex fusion protein. Immunoprecitpitated ZO-1 or inacti- 
vated Sepharose associated proteins were analyzed in an in vitro ki- 
nase assay in the presence (lanes 1,2) or in the absence (lanes 3,4) 
of GST-PDZ3-SH3ex fusion protein. The position of the GST- 
PDZ3-SH3ex fusion protein is indicated with an arrow. 
with the molecular weight of the fusion protein was only ob- 
served in its presence (compare lanes 2 and 4) indicating that 
this phosphorylated band indeed corresponded to the fusion 
protein. Interestingly, in the absence as well as presence of the 
fusion protein, four other phosphorylated bands could be ob- 
served. While the high molecular mass bands are likely to 
correspond to ZO-1 (210 kDa), ZO-2 (160 kDa) and p130, 
all three are known to be phosphoproteins [39]. The identity 
of the band migrating at approx. 52 kDa is not clear but 
could be either immunoglobulin heavy chain or an uncharac- 
terized protein. 
This result indicates that a kinase capable of phosphorylat- 
ing the GST-PDZ3-SH3ex fusion protein is also associated 
with ZO-1 immunoprecipitated from MDCK cell extracts. 
This suggests that a kinase that associates with and phosphor- 
ylates the fusion protein containing the third PDZ domain 
and the SH3 domain of ZO-1 also associates with ZO-1 in 
vivo. 
4. Discussion 
We found that fusion proteins containing the SH3 domain 
of ZO-1 bind to a protein kinase that phosphorylates serine 
residue(s) C-terminal to the binding domain. A similar kinase 
activity co-immunoprecipitated with ZO-1 extracted from 
MDCK cells. Since ZO-1 is phosphorylated in vivo in Ser 
and this kinase appears to bind specifically to the SH3 domain 
of ZO-1 and not to other SH3 domains tested, we propose to 
call this serine protein kinase ZAK (ZO-1 Associated Kinase) 
until further characterization. 
Our results are significant in several aspects. First, even 
though there are many publications on the involvement of 
kinases in the assembly and disassembly of tight junctions 
and ZO-I is a phosphoprotein, this is the first time a kinase 
has been shown to interact directly with one of the compo- 
nents of this intercellular junction. Second, while it is known 
that ZO-1 directly or indirectly interacts with several other 
proteins, this is the first time that such an interaction has 
been localized to a particular domain of this protein. Third, 
since ZO-1 is a putative tumor suppressor, this interacting 
kinase is not only potentially involved in the regulation of 
tight junctions but might also be involved in the regulation 
of cell growth and differentiation. Fourth, ZAK not only ex- 
tends the short list of kinases specifically interacting with a 
particular SH3 domain but is also the first one that in addi- 
tion phosphorylates a region C-terminal to the SH3 domain. 
Many pharmacological experiments have been reported that 
suggest hat protein kinases are involved in the regulation of 
the sealing of tight junctions (see Section 1). Furthermore, 
antibodies against E-cadherin, an epithelial calcium-depend- 
ent cell-cell adhesion molecule, perturb cell-cell contact [55] 
and inhibit the assembly of the tight junction triggered by 
the addition of calcium [56]. Interestingly, the cell-cell contact 
perturbation can be prevented by activation of protein kinase 
A [57] or by the addition of diC8, suggesting an involvement 
of protein kinase C [39]. Other experiments confirmed the 
possible participation of protein kinase C in the assembly of 
tight junctions [49,50]. Moreover, protein kinases are also in- 
volved in the disassembly of tight junctions [40]. While the 
drugs generally used suggest an involvement of protein ki- 
nases C, A and tyrosine kinases, it is still not clear whether 
the observed alterations were due to direct or indirect effects. 
Furthermore, no kinase has so far been shown to interact with 
any of the known components of tight junctions. Therefore, 
the serine protein kinase activity described in this paper is an 
attractive candidate for a kinase directly involved in the as- 
sembly and sealing of tight junctions. The total phosphate 
content of ZO-1 is different in two strains of MDCK cells 
which differ in transepithelial resistance [30], however, it is 
the same [39] or just slightly different [58,50] in low versus 
high calcium cells. This apparent contradiction could mean 
that the total phosphocontent does not significantly change 
but that the phosphocontent a specific sites might change 
[58]. ZAK appears to phosphorylate ZO-1 itself, it will be 
of interest o analyze further whether this protein kinase is 
involved in the assembly of the junction. Interestingly, essen- 
tially all of the protein kinase inhibitors tested affect not only 
assembly but also disassembly, which could mean that the 
same kinase(s) are regulating both processes. Thus, transient 
phosphorylations might be involved in the mobilization of 
junctional components or the dissociation of existing interac- 
tions. Other factors like cell-cell interactions or cytoskeletal 
architecture then determine whether upon phosphorylation r
dephosphorylation ZO-1 will be used for the assembly of tight 
junctions or associates with other components, for instance, I]- 
catenin, an interaction that takes place in the absence of cal- 
cium and assembled tight junctions [59]. 
Since a serine kinase activity was also found to co-immu- 
noprecipitate with ZO-1 from cell extracts derived from 
MDCK cell monolayers, it could also be that ZAK regulates 
an interaction occurring within assembled tight junctions. ZO- 
1 was found to interact directly in vitro with the C-terminal 
domain of occludin, the only known transmembrane protein 
of tight junctions [60]. Furthermore, xperiments using stably 
transfected MDCK cells expressing wild-type or mutant 
chicken occludin suggested that the C-terminal domain of 
occludin is important for the regulation of epithelial paracel- 
lular permeability [61]. Hence, one could also imagine that 
ZAK regulates the interaction between the C-terminal cyto- 
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plasmic domain of occludin and ZO-1 and, thereby, paracel- 
lular permeability. 
Another interesting feature of ZO-1 is that it belongs to a 
family of proteins homologous to disc large A, a tumor sup- 
p:'essor protein originally identified in Drosophila that loca- 
lizes at the septate junction [2]. Besides the SH3 domain, all 
n~embers of this family possess three PDZ domains and a 
gmnylate kinase domain. While no associated protein for 
tile domain homologous to guanylate kinase has been re- 
ported, PDZ domains of a neuronal member of this protein 
f tmily, PSD95/SAP90, have been described to mediate inter- 
actions with NMDA-receptor, ion channels as wells as nitric 
oxide synthase (reviewed in [16]). In the case of ZO-1, how- 
e Jer, no proteins are known to interact specifically with any of 
i s  domains. We have now shown that its SH3 domain inter- 
~,cts with a serine protein kinase. Because of the tumor sup- 
t,ressor activity of disc large A and, the role of lin-2 in differ- 
entiation [3], it is tempting to speculate that other members of 
1 ais family might have a similar activity and, therefore, ZAK 
ould also be part of a signal transduction mechanism of tight 
j mctions involved in the regulation of cell growth and differ- 
cntiation. Interestingly, mutations in the SH3 and guanylate 
I inase domain of dlgA cause loss of normal cell proliferation 
control [62]. 
As mentioned in Section 1, binding of protein kinases to 
:,H3 domains is a new type of interaction recently identified 
1or the SH3 domains of Src and Nck [26,25]. The fact that the 
Y,H3 domain of ZO-I associates with a protein kinase suggests 
l hat this type of binding partner for SH3 domains might be a 
~aore general phenomena. More importantly, in the case that 
're describe here, the protein kinase not only associated with 
he  SH3 domain but also phosphorylated sequences pecific 
,?-terminal to the SH3 domain. This suggests that kinase 
Jinding to the SH3 domain of a protein can have direct struc- 
ural and, most likely, functional consequences for the pro- 
ein. 
The approach and observations described here open up new 
~ossibilities to look at how tight junction assembly and func- 
ion  are regulated by kinases. Once the chemical identity of 
this kinase has been determined, it will possible to express it in 
t wild-type or mutant configuration and study the physiolog- 
cal consequences. 
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